MDMA, better known as the illegal drug Ecstasy, has shown promise for treating people with post-traumatic stress disorder. Now the FDA has granted the drug “breakthrough” status, and a phase 3 trial could begin as early as spring 2018.
MDMA, better known as the illegal drug Ecstasy, has shown promise for treating people with post-traumatic stress disorder. Now the FDA has granted the drug “breakthrough” status, and a phase 3 trial could begin as early as spring 2018.
0 comments :
Post a Comment